Vision Quest 2013
Listen to informative lectures and discussions from Vision Quest 2013!
Ride for Sight
Join us for Canada's biggest and longest-running motorcycle charity ride. The best party of the summer!
Cycle for Sight
Join us for Cycle for Sight and see what you're made of!
Share the laughter. See the hope. Join us for the 2013 Comic Vision tour & Comic Vision: Last Call - the most fun-filled, casual fundraising events of the season!
News & Events
New Compound May be the Basis of a Promising Drug to Reverse Retinal Blindness
Feb 21, 2014 - California researchers invent a new "photoswitch," which may give light-sensing capacity to retinal nerve cells potentially restoring vision to people with advanced retinal degenerative diseases.
Dr. Bill Stell Reflects on the Foundation History of Sight-Saving Research
Feb 10, 2014 - For nearly 30 years, Dr. Bill Stell has volunteered his time and scientific expertise to help the Foundation Fighting Blindness select and fund scientific projects with the power to make a difference. We talked to him about how the science has changed over the past 40 years, and why he continues to be a passionate advocate for the Foundation.
Shorcan Brokers Ltd. donates over $10,000 to help vision research
Feb 11, 2013 - The 16th annual Shorcan Brokers Ltd. Charity Day raised a total of $10,827 for the Foundation Fighting Blindness. This is the 6th year Shorcan, TMX Group's fixed income interdealer brokerage, has supported the Foundation, bringing their total contribution to $61,362!
The unique one-day event contributed proceeds from the day's trading to select charities, among them the Foundation Fighting Blindness.
Testing the Safety of Induced Stem Cell Therapies
Feb 5, 2014 - Cells derived from induced pluipotent stem cells will soon be used in a clinical trial for dry age-related macular degeneration and may be used for other conditions as well. How are scientists addressing concerns about the potential cancer risk?
Forty years ago, Jay and Malca Marin applied to become a registered charity to fight blindness
Jan 20, 2014 - Forty years ago, Jay and Malca Marin applied to become a registered charity to fight blindness – and were rejected. But they didn’t give up. Instead, they dedicated their lives to creating the Foundation Fighting Blindness (then RP Foundation). Today, it’s Canada’s leading charity funding sight-saving research.
First gene therapy results for choroideremia suggest cautious optimism
Jan 16, 2014 - Results of the first six patients treated in the British gene therapy trial for choroideremia were released today. While many questions remain unanswered, the two most visually impaired participants experienced significant vision improvements. Canadian investigators at the University of Alberta will be able to build on these results, as the treatment of trial participants there will begin later this year.
Personal Genetics Service, 23andme, Forced to Discontinue Genetic Health Reports
Jan 15, 2014 - Recently, the American Food and Drug Administration barred the personal genetics firm 23andme from offering health reports to its clients. Does this mean that genetic testing is unreliable? The answer is a clear no, but the case is an opportunity to talk about the different ways that genetic information is now being used and the methods used to do that testing.
Allergies may protect against age-related macular degeneration
Jan 8, 2014 - In a new, and unexpected, research finding people with a history of allergies to common substances such as pollen, animals or foods, may be less likely to have AMD.
Capital One Canada Competition Results in $35,000 Donation to the Foundation Fighting Blindness
Dec 19, 2013 - The Foundation is honoured to win Capital One Canada’s “Who wants to be a Philanthropist” associate contest.
Vision Researcher talks about his own Experiences with Retinitis Pigmentosa
Nov 20, 2013 - Stuart Lithwick is a PhD candidate training in Dr. Valerie Wallace's research laboratory at Toronto Western Hospital. These scientists are working towards a way to restore vision to those of have lost all or most of their sight.
Stuart is also living with retinitis pigmentosa. On CBC Metro Morning, he talked about what being part of this research means to him and how he was inspired to return to a research career at Vision Quest in 2010.
Foundation Fighting Blindness Patient Registry Now Enrolling in Halifax
Oct 22, 2013 - The Foundation Fighting Blindness Patient Registry is a tool to help connect people living with inherited eye diseases (such as retinitis pigmentosa or Stargardt disease) to scientists studying these conditions. By participating in the Registry, you can help create a database of information so that scientists can better study and understand these conditions and so they can find participants for clinical trials. IWK Health Centre in Halifax has just joined the list of centres where you can enrol in the Registry. The link below offers more information about the registry including contact information for the Halifax site.
Ocular Gene Therapy Centre Established at the University of Alberta
Oct 9, 2013 - A multi-million dollar investment by the Alberta government will create a unique centre for testing gene therapies for inherited eye disease.
2012 Annual Report
Accountable to You
Our 2012 Annual Report is now available. It’s just one more way we’re accountable to you, our community of dedicated donors, sponsors, volunteers, event participants, researchers and individuals and families living with vision loss.
In it you’ll read about the hope your support provides to just three of the 1 million Canadian families living with vision loss. You’ll also find updates from our signature fundraising events: Ride for Sight, Comic Vision, and Cycle for Sight, as well as information on our Vision Quest educational series, and, of course, our audited financial statements.
Your donations supported a total of 23 ongoing research projects across the country in 2012 – over $1.8 million in new Canadian vision research. And thanks to your generosity, Foundation research funding increased 35% in 2012 over 2011.
Our 2012 Annual Report is also an expression of our deep gratitude for your commitment to vision research and our mission to understand, preserve and restore sight.